Stroke‐related death within 30 days of surgery (worst‐case) · patients with symptomatic or asymptomatic carotid disease
Shunting showed no clear difference in stroke‐related death within 30 days of surgery (worst‐case) compared with no shunting (low certainty).
1 finding from 1 review
Any stroke during surgery (best‐case) · patients with symptomatic or asymptomatic carotid disease
Shunting showed no clear difference in any stroke during surgery (best‐case) compared with no shunting (low certainty).
1 finding from 1 review
Any stroke during surgery (worst‐case) · patients with symptomatic or asymptomatic carotid disease
Shunting showed no clear difference in any stroke during surgery (worst‐case) compared with no shunting (low certainty).
1 finding from 1 review
Any stroke within 24 hours of surgery · patients with symptomatic or asymptomatic carotid disease
Shunting may leads to lower any stroke within 24 hours of surgery compared with no shunting (low certainty).
1 finding from 1 review
Stroke · patients with symptomatic or asymptomatic carotid disease
Shunting showed no clear difference in any stroke within 30 days of surgery compared with no shunting (low certainty).
1 finding from 1 review
Reoperation · (mainly older) adults with most types of displaced proximal humeral fracturesa (10 trials)
Surgical may leads to higher additional surgery (reoperation or secondary surgery) compared with non‐surgical treatment (low certainty).
1 finding from 1 review
Additional surgery or substantive treatment · adults with minimally displaced or displaced (2‐part or 3‐part) proximal humeral fractures treated non‐surgically (5 trials)
1 finding from 1 review
Surgery ‐ within 30 days · people with upper gastrointestinal bleeding prior to endoscopic diagnosis
Proton pump inhibitor treatment showed no clear difference in surgery ‐ within 30 days compared with H2RA, placebo or no treatment (low certainty).
1 finding from 1 review
Intervention not reported
Secondary ‐ Long‐term emergency surgery during · Patients with acute uncomplicated diverticulitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Primary ‐ Short‐term emergency surgery within 30 days · Patients with acute uncomplicated diverticulitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Secondary ‐ Long‐term emergency surgery during · Patients with acute uncomplicated diverticulitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Primary ‐ Short‐term emergency surgery within 30 days · Patients with acute uncomplicated diverticulitis
The intervention showed no clear difference in primary ‐ Short‐term emergency surgery within 30 days (low certainty).
1 finding from 1 review
Intervention not reported
Secondary ‐ Long‐term emergency surgery during · Patients with acute uncomplicated diverticulitis
The intervention showed no clear difference in secondary ‐ Long‐term emergency surgery during (low certainty).
1 finding from 1 review
Intervention not reported
Primary ‐ Short‐term emergency surgery within 30 days · Patients with acute uncomplicated diverticulitis
The intervention showed no clear difference in primary ‐ Short‐term emergency surgery within 30 days (low certainty).
1 finding from 1 review
Scar severity ‐ carbon dioxide (CO2) laser plus TAC versus cryosurgery plus TAC. Mean percentage reduction ‐ blinded observer assessment ‐ keloid scars ‐ · participants with hypertrophic and keloid scars
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Scar severity ‐ CO2 laser plus TAC versus cryosurgery plus TAC Mean percentage reduction ‐ patient self‐assessment score (higher scores = worse scar appearance) ‐ keloid scars ‐ · participants with hypertrophic and keloid scars
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Incidence of treatment‐related adverse effects: CO2 laser plus TAC versus cryosurgery plus TAC ‐ atrophy ‐ keloid scars ‐ · participants with hypertrophic and keloid scars
It is very uncertain whether laser therapy plus other treatment changes incidence of treatment‐related adverse effects: CO2 laser plus TAC… compared with other treatment (very low certainty).
1 finding from 1 review
RR 1.13 [0.7, 1.82]
Studies not reported
Very low
Incidence of treatment‐related adverse effects ‐ CO2 laser plus TAC versus cryosurgery plus TAC ‐ erythema ‐ keloid scars ‐ · participants with hypertrophic and keloid scars
It is very uncertain whether laser therapy plus other treatment changes incidence of treatment‐related adverse effects ‐ CO2 laser plus TAC… compared with other treatment (very low certainty).
1 finding from 1 review
RR 1.5 [0.47, 4.78]
Studies not reported
Very low
Incidence of treatment‐related adverse effects ‐ CO2 laser plus TAC versus cryosurgery plus TAC ‐ telangiectasia ‐ keloid scars ‐ · participants with hypertrophic and keloid scars
It is very uncertain whether laser therapy plus other treatment changes incidence of treatment‐related adverse effects ‐ CO2 laser plus TAC… compared with other treatment (very low certainty).
1 finding from 1 review
RR 0.33 [0.07, 1.52]
Studies not reported
Very low
Incidence of treatment‐related adverse effects ‐ CO2 laser plus TAC versus cryosurgery plus TAC ‐ hypopigmentation ‐ keloid scars ‐ · participants with hypertrophic and keloid scars
It is very uncertain whether laser therapy plus other treatment changes incidence of treatment‐related adverse effects ‐ CO2 laser plus TAC… compared with other treatment (very low certainty).
1 finding from 1 review
RR 0.6 [0.16, 2.29]
Studies not reported
Very low